Published in EJIFCC on December 20, 2008
High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45
Inflammation in atherosclerosis. Nature (2002) 28.92
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2000) 14.59
The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol (1995) 4.60
Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol (2000) 2.66
Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics (2005) 1.88
Proteomic analysis of high-density lipoprotein. Proteomics (2006) 1.82
Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics (2005) 1.44
Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation (2004) 1.33
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis (2008) 1.14
Two-dimensional maps and databases of the human macrophage proteome and secretome. Proteomics (2004) 1.11
Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOF. Proteomics (2007) 1.10
Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb Vasc Biol (2003) 1.08
Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics (2005) 1.08
Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics (2003) 1.07
In vitro biomarker discovery for atherosclerosis by proteomics. Mol Cell Proteomics (2004) 1.04
F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress: a proteonomic approach. Mol Cell Proteomics (2003) 1.04
Proteomic study of human umbilical vein endothelial cells in culture. Proteomics (2003) 1.04
The proteome and secretome of human arterial smooth muscle cells. Proteomics (2005) 1.02
Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics (2003) 1.01
Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins. Proteomics (2006) 0.98
Cap G, a gelsolin family protein modulating protective effects of unidirectional shear stress. J Biol Chem (2003) 0.94
Proteomic analysis of differential protein expression in human atherosclerotic plaque progression. J Pathol (2005) 0.93
Proteomic and metabolomic analysis of vascular smooth muscle cells: role of PKCdelta. Circ Res (2004) 0.92
Proteome of monocytes primed with lipopolysaccharide: analysis of the abundant proteins. Proteomics (2003) 0.91
Searching for genes involved in arteriosclerosis: proteomic analysis of cultured human umbilical vein endothelial cells undergoing replicative senescence. Cell Struct Funct (2003) 0.88
Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. Eur J Pharmacol (2007) 0.88
Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid. Proteomics (2004) 0.85
Proteomic analysis of differential protein expression in atherosclerosis. Biomarkers (2006) 0.80